HHS Halts Funding for Development of Next-Generation COVID Biologics
The U.S. Department of Health and Human Services (DHHS) has stopped U.S. government funding for the development of next-generation COVID-19 biologics by two companies, GeoVax, Inc. of Atlanta, Georgia and CastleVax, Inc. of New York. The project had been funded by Project NextGen, a Biden administration initiative under the U.S. Center for the Biomedical Advanced […]
Guillain-Barré Syndrome Warning Added to Shingrix Vaccine in Australia
In February 2024, Australia’s Therapeutic Goods Administration (TGA), the country’s national regulatory authority for drugs and, initiated an investigation into a potential association between GSK plc’s Shingrix shingles vaccine, Guillain-Barré syndrome (GBS), which causes inflammation and damage to the nerves, that may include paralysis.1 The investigation was prompted by two reports of GBS following Shingrix […]
U.S. Government Accused of Hiding Deadly E. Coli Outbreak
A deadly E. coli outbreak reportedly linked to food was kept hidden by the U.S. government health agencies according to a new lawsuit. The California legal case alleges that a November 2024 E. coli outbreak sickened 89 people in 15 states.1 One person died while 36 others were hospitalized, including a nine-year-old boy who suffered […]
Pfizer Ends Development of Weight-Loss Pill After Liver Injury in Trial Participant
Pfizer, Inc. announced that it is discontinuing development of its experimental daily weight loss pill after a trial participant suffered a liver injury potentially linked to the drug. The company confirmed that the oral GLP-1 drug, danuglipron (PF-06882961), is no longer in development following the incident.1 Pfizer has been studying danuglipron since 2022.2 A Pfizer […]
Moderna Continues mRNA Norovirus “Vaccine” Trials Following Guillain-Barré Case
A first-ever norovirus “vaccine”—another experimental biological product produced by Moderna, Inc., using novel mRNA technology—may be on the horizon even though last month the U.S. Food and Drug Administration (FDA) paused Moderna’s late-stage clinical trial following a report of Guillain-Barré syndrome (GBS), a rare neurological side effect that has also surfaced in its RSV vaccine […]
Nearly Half of Baby Formulas Tested Contain Lead and Arsenic
After testing 41 types of powdered baby formula, Consumer Reports (CR) reported the presence of harmful contaminants in nearly half of those tested. Contaminants included arsenic, lead, and “forever chemicals” such as PFAS.1 Only a day after sharing test results with the U.S. Food and Drug Administration (FDA), the agency announced a new initiative to strengthen […]